(84% neutrophils, 13% lymphocytes, 2% monocytes, 1% eosinophils), platelets 130,000/μL, hemoglobin 12.5 g/dL, glucose 102 mg/dL, blood urea 28.3 mg/dL, creatinine 0.9 mg/dL, aspartate aminotransferase (AST) 20.4 U/L, alanine aminotransferase (ALT) 54.4 U/L, erythrocyte sedimentation rate (Katz index) 15 mm/h, prothrombin time ratio 1.02, partial thromboplastin time -2.8 s. Radiographs of the thorax showed bilateral infi ltrate. Echocardiogram showed minor tricuspid insuffi ciency. Serologic tests were negative for Epstein-Barr and hepatitis B and positive for cytomegalovirus and hepatitis A viruses. Blood and stool cultures were negative. Blood samples were taken 4 and 35 days after illness onset; buffy-coat smears were stained with Dip Quick (Jorgensen Laboratories, Inc., Loveland, CO, USA), and immunologic and PCR tests were performed. Immunoglobulin (Ig) M against dengue virus was present at days 4 and 35 of illness; IgG against dengue was absent on day 4 and present on day 35. PCR and viral isolation tests for dengue virus were negative. Serologic tests for E. chaffeensis (indirect immunofl uorescence) were also negative on day 4 and positive (256) on day 35. Detection of Ehrlichia species-specifi c DNA was performed by using nested PCR as described (7) .
Starting on the fi rst day of hospitalization, the patient was treated with doxycycline (14 days) and chloramphenicol (8 days). After 24 hours, malaise, headache, facial edema, and conjunctivitis improved. After 48 hours, fever and rash were gone. After 3 days, his appetite improved; progressively over time, cervical adenomegaly and cutaneous lesions improved. Abdominal pain persisted for 7 days after treatment. Nausea and vomiting started 2 days after admittance; on day 7, vomit was of coffee-ground consistency. All remaining symptoms abated thereafter. The patient had diarrhea during days 3-6 after admittance; hepatomegaly disappeared after 4 days. Ultrasonographic images of the abdomen indicated acute cholecystitis and hepatosplenomegaly; endoscopic examination of the upper digestive tract showed hyperplasia, hyperemia, and linear and pseudomembranous lacerations in the middle and distal thirds of the esophagus (Mallory-Weiss syndrome) and moderate erythema of the stomach. Test results for Helicobacter pylori and Giardia lamblia were negative.
Laboratory results showed leukopenia and monocytosis on day 5 of illness. Leukocyte count was within reference range thereafter; thrombocytopenia was present until day 7 (99,000/mm 3 ). ALT was elevated from day 3 and peaked (481 IU) on day 7. AST levels increased on day 5 and peaked (215 IU) on day 7. Both values decreased progressively to reference levels (after 25 days for ALT and 46 days for AST). Lactic dehydrogenase was elevated for 9 days while erythrocyte count, sedimentation rate, and serum glucose, amylase, urea, creatinine, bilirubin, calcium, sodium, and potassium remained within reference limits. The patient was released after 8 days of hospitalization.
The buffy-coat smear performed 4 days after illness onset showed basophilic intracytoplasmic inclusions inside vacuoles of lymphocytes and monocytes, with typical features of morulae reported for human monocytic ehrlichiosis (Figure) . Nested PCR analysis was positive for E. chaffeensis, and sequencing of the amplifi ed DNA fully confi rmed the 16S rRNA targeted sequence.
This report provides molecular evidence of E. chaffeensis infection in a patient with acute disease in Venezuela. A previous case of human monocytic ehrlichiosis in a 17-month-old girl in Venezuela has been demonstrated serologically (2) . E. canis in an asymptomatic patient in Venezuela has been demonstrated by PCR and culture isolation (8) and was recently demonstrated in symptomatic patients (9) . Excluding the esophageal lesions (Mallory-Weiss syndrome), our case is compatible with cases reported previously (10) . The clinical manifestations of ehrlichiosis are similar to those of dengue fever and mononucleosis, both common diseases in Venezuela. The positive anti-dengue IgM and the seroconversion of the IgG together with the negative PCR and isolation results suggest a recent, inactive infection with dengue virus.
According to our fi ndings, ehrlichiosis should be a differential diagnosis for febrile patients who have thrombocytopenia, hepatomegaly, and recent exposure to ticks. Although Amblyomma americanum, the main known vector of E. chaffeensis, has not been reported in Venezuela, Rhipicephalus sanguineus and A. cajennense are abundant in rural areas of Venezuela; their ability to be vectors should be investigated.
Resource Allocation during an Infl uenza Pandemic
To the Editor: Planning for pandemic infl uenza is accepted as an essential healthcare service and has included creation of national and international antiviral drug stockpiles and novel approaches to emergency vaccine development (1) . The effectiveness of these strategies in a pandemic may be substantial but is unknown. More certain is that effective management of severe and complicated infl uenza will reduce deaths and that demand will exceed available treatment resources (2) . Appropriate allocation of treatment resources is therefore essential, perhaps more important than any specifi c treatment such as administering antiviral medication to symptomatic patients. Re- 
